Annual report pursuant to Section 13 and 15(d)

Equity based compensation - Summary of stock options (Details)

v3.22.0.1
Equity based compensation - Summary of stock options (Details)
12 Months Ended
Dec. 31, 2021
$ / shares
shares
Reload Options [Member]  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Number of options, Granted | shares 4,592,319
Number of options, Ending of period | shares 4,592,319
Weighted average exercise price, granted $ 23.50
Weighted Average Grant Date Fair Value, End of period $ 23.50
Staking Options [Member]  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Number of options, Granted | shares 66,667
Number of options, Ending of period | shares 66,667
Weighted average exercise price, granted $ 23.50
Weighted Average Grant Date Fair Value, End of period $ 23.50
Class C Incentive Units [Member]  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number | shares 3,911,490
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares 3,911,490
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 23.50
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value $ 23.50
Class C Incentive Unit Staking Options [Member]  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number | shares 2,116,667
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares 2,116,667
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | $ / shares $ 23.50
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value 23.50
Weighted average exercise price, granted $ 12.02